Two-Year Total-Body Vitrification and Successful Revival in Pan troglodytes
Russo, S., et al. — Luna Research Dome 4 — 2131 ES
Abstract
Long-duration total-body vitrification has been proposed as a prerequisite technology for extended interplanetary and interstellar transit, but no prior study has demonstrated survival and functional recovery in a large mammalian subject beyond several months of continuous suspension. We report the successful vitrification, two-year continuous suspension, and full revival of an adult chimpanzee (Pan troglodytes, female, age 14 at induction), representing the longest confirmed large-primate cryopreservation interval with a surviving, cognitively assessed subject at endpoint.
Vitrification was achieved through a multi-stage cryoprotectant perfusion protocol supplemented with ice-binding proteins derived from extremophile source organisms, suppressing ice nucleation across the induction window. Revival employed nanoparticle-mediated alternating-magnetic-field rewarming to achieve rapid, volumetric temperature elevation through the critical devitrification range (−130°C to −40°C), followed by staged cryoprotectant washout via total-body perfusion and near-infrared photobiomodulation targeting cytochrome c oxidase to support graduated mitochondrial reactivation. Continuous ion-balance monitoring was maintained throughout the rewarming sequence to guard against uncontrolled cellular depolarization.
The subject was successfully revived with no evidence of gross neurological injury, and remains under longitudinal behavioral and cognitive assessment at time of publication. We note that all systems used during induction, suspension, and revival operated under narrowly defined, single-function control parameters; no aspect of the protocol required or employed general adaptive judgment beyond pre-specified response thresholds.
We caution against extrapolating these results directly to human application or to suspension durations beyond the two-year interval demonstrated here. Cryoprotectant toxicity thresholds, rewarming uniformity, and staged metabolic reactivation all scale non-linearly with subject mass and physiological complexity, and each will require independent re-validation at human scale before any human trial can be responsibly considered.
See Also
- Luna Interplanetary News: Russo Cryosleep Interview (2131) — public-facing interview
- Dr. Sofia Russo — lead author
- TWN: James E. Crawford on The Ark (2130) — generational ship, contemporaneous context
Sources
- Luna Research Dome 4, Internal Journal of Applied Cryobiology (2131)
- Luna Interplanetary News, Dr. Sofia Russo interview transcript (2131)